The new biosimilar medicine from Lek, a Sandoz company, strengthens the well-established Sandoz immunology portfolio in Slovenia and across Europe.
The new biosimilar medicine from Lek, a Sandoz company, strengthens the well-established Sandoz immunology portfolio in Slovenia and across Europe.
ISDO – international business platform driving the global shift to sustainable development by promoting awareness, innovation, leadership, education, and investment. ISDO fosters international collaboration, supports sustainable technologies, and connects stakeholders to scale impactful solutions for a more sustainable future.
ISDO.ORG | All Right Reserved.